There are 147 resources available
Direct and indirect anti-cancer effects of PI3K isoforms’
Presenter: Bart Vanhaesebroeck
Session: Targeting the PI3K pathway in human epithelial malignancies'
Resources:
Presentation
Webcast
Predictive markers of PIK3CA efficacy
Presenter: Fabrice André
Session: Targeting the PI3K pathway in human epithelial malignancies'
Resources:
Presentation
Webcast
Targeting EGFR exon 20 insertions in non-small cell lung cancer by exploiting a dependency on parallel SRC signalling
Presenter: Simon Vyse
Session: Targeting the PI3K pathway in human epithelial malignancies'
Resources:
Abstract
Predictive biomarkers for the efficacy of IO: which biomarkers to use for daily use?
Presenter: John Haanen
Session: Biomarkers and checkpoint inhibitor
Resources:
Presentation
Webcast
Predictive biomarkers for the efficacy of IO: What’s in the pipeline
Presenter: Daniela Thommen
Session: Biomarkers and checkpoint inhibitor
Comprehensive genomic profiling and outcomes among metastatic melanoma patients (pts) treated with first-line cancer immunotherapy (CIT) in a real-world setting
Presenter: Yibing Yan
Session: Biomarkers and checkpoint inhibitor
Resources:
Abstract
Contrasting the drivers of response to immunotherapy across solid tumour types: Results from analysis of > 1000 cases
Presenter: Kevin Litchfield
Session: Biomarkers and checkpoint inhibitor
Resources:
Abstract
Personalised therapy based on comprehensive genomic profiling
Presenter: Jason Sicklick
Session: Industry satellite - Roche: Novel approaches in personalised healthcare
Resources:
Presentation
Webcast
Interactive patient case focused on comprehensive genomic profiling resulting in treatment with combination therapies
Presenter: Jason Sicklick
Session: Industry satellite - Roche: Novel approaches in personalised healthcare
Resources:
Webcast
Use of liquid biopsy based genomic profiling
Presenter: Dominic Rothwell
Session: Industry satellite - Roche: Novel approaches in personalised healthcare
Resources:
Webcast